28 September,2020 07:06 AM IST | Mumbai | Arita Sarkar
The trial at Nair Hospital will have 100 participants. File pic
After KEM Hospital, Nair Hospital is all set to begin the Oxford vaccine trial with four candidates on Monday. Meanwhile, the screening process for more candidates is underway at both hospitals.
As part of the trial, Nair Hospital will have 100 participants while KEM hospital will have 150. Nair Hospital's dean Dr Ramesh Bharmal said that so far, around 50 people who had registered for the trial have been screened. "After carrying out RT PCR and antibody tests, we have found 19 eligible candidates who fit the criteria for the trial. Three of them are women. We will start with four candidates for the vaccine trial," he said, adding that one of the four will receive a placebo.
Also Read: COVID-19: With 2,261 new cases, Mumbai approaches two-lakh mark
Senior civic officials said that 10 more people were screened at KEM Hospital on Sunday. "We have selected four candidates who are eligible for the trial. They will receive a dose of the vaccine on Monday," said the official. The trial started at KEM Hospital two days ago with three candidates who received the dose of the vaccine. They were kept for observation for an hour before they were sent home.
ALSO READ
Police swarm Georgia high school after it's placed on lockdown as students evacuated to stadium
Why more men are turning to crocheting
Alia Bhatt: I avoid giving parenting advice as everyone’s journey is different
Alpha Beta Gamma – The Relationship Story Of The Year
Delhi: Ghost patients scam unravels at Mohalla clinics
50
No. of people screened by Nair Hospital for the trial
19
No. of people found eligible to get the vaccine
Catch up on all the latest Mumbai news, crime news, current affairs, and a complete guide from food to things to do and events across Mumbai. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news